NEUROONE MEDICAL TECHNOLOGIES Corp
NMTC Nasdaq
SEC CIK 1500198
Follow Neuroone Medical Technologies
Weekly email: filings, results
Revenue, last quarter
$2M
+16.3% vs same quarter last year
Net income
−$2M
−33.7% vs same quarter last year
EPS, diluted
−$0.28
−47.4% vs same quarter last year
Operating cash flow
−$1.1M
+26.1% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $9.1M | −$3.6M |
| FY24 | $3.5M | −$12.3M |
| FY23 | $2M | −$11.9M |
| FY22 | $171.2K | −$10M |
| FY21 | $178.1K | −$9.9M |
| FY20 | - | −$13.6M |
| FY19 | - | −$6.8M |
| FY18 | - | −$5.1M |
| FY17 | $0 | −$47.8K |
| FY16 | $0 | −$62.9K |
| FY15 | $773 | −$36.2K |
| FY14 | $1.2K | −$30.6K |
| FY13 | $921 | −$14K |
| FY12 | $5.4K | −$27.6K |
| FY11 | $1.2K | −$6K |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 56.5% | −46.5% | −39.6% |
| FY24 | 31.3% | −344.3% | −356.7% |
| FY23 | 23.4% | −612.3% | −607.4% |
| FY22 | −41.4% | −5860.2% | −5842% |
| FY21 | −54.9% | −5735.9% | −5584.3% |
| FY20 | - | - | - |
| FY19 | - | - | - |
| FY18 | - | - | - |
| FY17 | - | - | - |
| FY16 | - | - | - |
| FY15 | - | −4646.1% | −4688.7% |
| FY14 | 100% | −2009% | −2446.3% |
| FY13 | 100% | −1491.1% | −1515.7% |
| FY12 | 60.4% | - | −511.4% |
| FY11 | 100% | - | −517.9% |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$2.9M |
| FY24 | −$11.1M |
| FY23 | −$13.3M |
| FY22 | −$7.8M |
| FY21 | −$8.7M |
| FY20 | −$3.5M |
| FY19 | −$5.5M |
| FY18 | - |
| FY17 | - |
| FY16 | - |
| FY15 | - |
| FY14 | - |
| FY13 | - |
| FY12 | - |
| FY11 | - |
- Neuroone Medical Technologies
- Healthcare median
Show the numbers
| Year | Neuroone Medical Technologies | Healthcare median |
|---|---|---|
| FY25 | −39.6% | −30.6% |
| FY24 | −356.7% | −47% |
| FY23 | −607.4% | −58% |
| FY22 | −5842% | −80.4% |
| FY21 | −5584.3% | −71.8% |
| FY20 | - | −62.2% |
| FY19 | - | −46.2% |
| FY18 | - | −49.6% |
| FY17 | - | −45.9% |
| FY16 | - | −36% |
| FY15 | −4688.7% | −37.8% |
| FY14 | −2446.3% | −35.5% |
| FY13 | −1515.7% | −37.1% |
| FY12 | −511.4% | −29.1% |
| FY11 | −517.9% | −27.9% |